{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:27:10Z","timestamp":1791534430337,"version":"4.3.4"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12035-025-04947-w","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:09:54Z","timestamp":1745485794000},"page":"14344-14366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Linking Metabolic Syndrome to Neurodegeneration Mechanisms and Potential Treatments"],"prefix":"10.1007","volume":"62","author":[{"given":"Amina","family":"D\u017eidi\u0107-Krivi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almir","family":"Fajki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma Karahmet","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Leki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Ejubovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samra Kadi\u0107","family":"Vukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malik","family":"Ejubovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Lepara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina Karahmet","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"4947_CR1","doi-asserted-by":"publisher","unstructured":"Tahmi M, Palta P, Luchsinger JA (2021) Metabolic syndrome and cognitive function. Curr Cardiol Rep 23(12). https:\/\/doi.org\/10.1007\/S11886-021-01615-Y","DOI":"10.1007\/S11886-021-01615-Y"},{"issue":"2","key":"4947_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/IJMS23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed G, Aoun L, Zerdan MB, Allam S, Zerdan MB, Bouferraa Y, Assi HI (2022) Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci 23(2):786. https:\/\/doi.org\/10.3390\/IJMS23020786","journal-title":"Int J Mol Sci"},{"issue":"10248","key":"4947_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A et al (2020) Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet (London, England) 396(10248):413\u2013446. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6","journal-title":"Lancet (London, England)"},{"issue":"1","key":"4947_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13098-022-00784-2\/TABLES\/4","volume":"14","author":"J Wang","year":"2022","unstructured":"Wang J, Bai Y, Zeng Z, Wang J, Wang P, Zhao Y, Xu W, Zhu Y et al (2022) Association between life-course cigarette smoking and metabolic syndrome: a discovery-replication strategy. Diabetol Metab Syndr 14(1):1\u201311. https:\/\/doi.org\/10.1186\/S13098-022-00784-2\/TABLES\/4","journal-title":"Diabetol Metab Syndr"},{"key":"4947_CR5","doi-asserted-by":"publisher","unstructured":"Wang L, Zhou Y, Fang X, Qu G (2022) Care burden on family caregivers of patients with dementia and affecting factors in China: a systematic review. Front Psych 13. https:\/\/doi.org\/10.3389\/FPSYT.2022.1004552","DOI":"10.3389\/FPSYT.2022.1004552"},{"issue":"5","key":"4947_CR6","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.3390\/IJMS24054354","volume":"24","author":"A Ezkurdia","year":"2023","unstructured":"Ezkurdia A, Ram\u00edrez MJ, Solas M (2023) Metabolic syndrome as a risk factor for Alzheimer\u2019s disease: a focus on insulin resistance. Int J Mol Sci 24(5):4354. https:\/\/doi.org\/10.3390\/IJMS24054354","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4947_CR7","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2337\/DC22-0206","volume":"45","author":"MD Machado-Fragua","year":"2022","unstructured":"Machado-Fragua MD, Fayosse A, Yerramalla MS, van Sloten TT, Tabak AG, Kivimaki M, Sabia S, Singh-Manoux A (2022) Association of metabolic syndrome with incident dementia: role of number and age at measurement of components in a 28-year follow-up of the Whitehall II cohort study. Diabetes Care 45(9):2127\u20132135. https:\/\/doi.org\/10.2337\/DC22-0206","journal-title":"Diabetes Care"},{"issue":"3","key":"4947_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","volume":"19","author":"VL Feigin","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M, Deuschl G, Parmar P et al (2020) The global burden of neurological disorders: translating evidence into policy. Lancet Neurol 19(3):255\u2013265. https:\/\/doi.org\/10.1016\/S1474-4422(19)30411-9","journal-title":"Lancet Neurol"},{"issue":"2","key":"4947_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/NU13020630","volume":"13","author":"A Noce","year":"2021","unstructured":"Noce A, Di Lauro M, Di Daniele F, Zaitseva AP, Marrone G, Borboni P, Di Daniele N (2021) Natural bioactive compounds useful in clinical management of metabolic syndrome. Nutrients 13(2):1\u201337. https:\/\/doi.org\/10.3390\/NU13020630","journal-title":"Nutrients"},{"issue":"13","key":"4947_CR10","doi-asserted-by":"publisher","first-page":"6862","DOI":"10.3390\/IJMS22136862","volume":"22","author":"TW Kao","year":"2021","unstructured":"Kao TW, Huang CC (2021) Recent progress in metabolic syndrome research and therapeutics. Int J Mol Sci 22(13):6862. https:\/\/doi.org\/10.3390\/IJMS22136862","journal-title":"Int J Mol Sci"},{"key":"4947_CR11","doi-asserted-by":"publisher","first-page":"100335","DOI":"10.1016\/J.FOCHA.2023.100335","volume":"3","author":"SM Mohamed","year":"2023","unstructured":"Mohamed SM, Shalaby MA, El-Shiekh RA, El-Banna HA, Emam SR, Bakr AF (2023) Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches. Food Chem Adv 3:100335. https:\/\/doi.org\/10.1016\/J.FOCHA.2023.100335","journal-title":"Food Chem Adv"},{"key":"4947_CR12","doi-asserted-by":"publisher","unstructured":"Mohajer B, Kwee RM, Guermazi A, Berenbaum F, Wan M, Zhen G, Cao X, Haugen IK, Demehri S (2021) Metabolic syndrome and osteoarthritis distribution in the hand joints: a propensity score matching analysis from the osteoarthritis initiative. J Rheumatol 48(10):1608\u20131615. https:\/\/doi.org\/10.3899\/JRHEUM.210189","DOI":"10.3899\/JRHEUM.210189"},{"issue":"1","key":"4947_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/J.JHEP.2022.08.030","volume":"78","author":"F \u00c5berg","year":"2023","unstructured":"\u00c5berg F, Byrne CD, Pirola CJ, M\u00e4nnist\u00f6 V, Sookoian S (2023) Alcohol consumption and metabolic syndrome: clinical and epidemiological impact on liver disease. J Hepatol 78(1):191\u2013206. https:\/\/doi.org\/10.1016\/J.JHEP.2022.08.030","journal-title":"J Hepatol"},{"key":"4947_CR14","doi-asserted-by":"publisher","first-page":"101451","DOI":"10.1016\/J.SMRV.2021.101451","volume":"59","author":"J Xie","year":"2021","unstructured":"Xie J, Li Y, Zhang Y, Vgontzas AN, Basta M, Chen B, Xu C, Tang X (2021) Sleep duration and metabolic syndrome: an updated systematic review and meta-analysis. Sleep Med Rev 59:101451. https:\/\/doi.org\/10.1016\/J.SMRV.2021.101451","journal-title":"Sleep Med Rev"},{"issue":"1","key":"4947_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3390\/ANTIOX11010079\/S1","volume":"11","author":"GK Jakubiak","year":"2022","unstructured":"Jakubiak GK, Osadnik K, Lejawa M, Osadnik T, Go\u0142awski M, Lewandowski P, Pawlas N (2022) \u201cObesity and insulin resistance\u201d is the component of the metabolic syndrome most strongly associated with oxidative stress. Antioxidants 11(1):79. https:\/\/doi.org\/10.3390\/ANTIOX11010079\/S1","journal-title":"Antioxidants"},{"issue":"3","key":"4947_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/MUS.27086","volume":"63","author":"M Kazamel","year":"2021","unstructured":"Kazamel M, Stino AM, Smith AG (2021) Metabolic syndrome and peripheral neuropathy. Muscle Nerve 63(3):285\u2013293. https:\/\/doi.org\/10.1002\/MUS.27086","journal-title":"Muscle Nerve"},{"issue":"3","key":"4947_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1055\/A-1263-0898\/ID\/R8170-0020\/BIB","volume":"42","author":"A Bovolini","year":"2021","unstructured":"Bovolini A, Garcia J, Andrade MA, Duarte JA (2021) Metabolic syndrome pathophysiology and predisposing factors. Int J Sports Med 42(3):199\u2013214. https:\/\/doi.org\/10.1055\/A-1263-0898\/ID\/R8170-0020\/BIB","journal-title":"Int J Sports Med"},{"issue":"01","key":"4947_CR18","doi-asserted-by":"publisher","first-page":"004","DOI":"10.1055\/S-0042-1760087","volume":"59","author":"A Mukhuty","year":"2023","unstructured":"Mukhuty A, Mondal SA, Mukhopadhyay S (2023) Hepatokines and adipokines in metabolic syndrome. Ann Nat Acad Med Sci (India) 59(01):004\u2013012. https:\/\/doi.org\/10.1055\/S-0042-1760087","journal-title":"Ann Nat Acad Med Sci (India)"},{"issue":"11","key":"4947_CR19","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3390\/BIOMEDICINES9111657","volume":"9","author":"AV Sitar-T\u01ceut","year":"2021","unstructured":"Sitar-T\u01ceut AV, Cozma A, Fodor A, Coste SC, Orasan OH, Negrean V, Pop D, Sitar-T\u01ceut DA (2021) New insights on the relationship between leptin, ghrelin, and leptin\/ghrelin ratio enforced by body mass index in obesity and diabetes. Biomedicines 9(11):1657. https:\/\/doi.org\/10.3390\/BIOMEDICINES9111657","journal-title":"Biomedicines"},{"issue":"9","key":"4947_CR20","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.3390\/IJERPH17093287","volume":"17","author":"KW Lee","year":"2020","unstructured":"Lee KW, Shin D (2020) Prospective associations of serum adiponectin, leptin, and leptin-adiponectin ratio with incidence of metabolic syndrome: the Korean Genome and Epidemiology study. Int J Environ Res Public Health 17(9):3287. https:\/\/doi.org\/10.3390\/IJERPH17093287","journal-title":"Int J Environ Res Public Health"},{"issue":"19","key":"4947_CR21","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1177\/2047487319895400","volume":"27","author":"R Ladeiras-Lopes","year":"2020","unstructured":"Ladeiras-Lopes R, Teixeira P, Azevedo A, Leite-Moreira A, Bettencourt N, Fontes-Carvalho R (2020) Metabolic syndrome severity score is associated with diastolic dysfunction and low-grade inflammation in a community-based cohort. Eur J Prev Cardiol 27(19):2330\u20132333. https:\/\/doi.org\/10.1177\/2047487319895400","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"4947_CR22","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/ANTIOX9030236","volume":"9","author":"M Monserrat-Mesquida","year":"2020","unstructured":"Monserrat-Mesquida M, Quetglas-Llabr\u00e9s M, Cap\u00f3 X, Bouzas C, Mateos D, Pons A, Tur JA, Sureda A (2020) Metabolic syndrome is associated with oxidative stress and proinflammatory state. Antioxidants 9(3):236. https:\/\/doi.org\/10.3390\/ANTIOX9030236","journal-title":"Antioxidants"},{"issue":"3","key":"4947_CR23","doi-asserted-by":"publisher","first-page":"e0194990","DOI":"10.1371\/JOURNAL.PONE.0194990","volume":"13","author":"N Assuncao","year":"2018","unstructured":"Assuncao N, Sudo FK, Drummond C, De Felice FG, Mattos P (2018) Metabolic Syndrome and cognitive decline in the elderly: a systematic review. PLoS ONE 13(3):e0194990. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0194990","journal-title":"PLoS ONE"},{"issue":"10","key":"4947_CR24","doi-asserted-by":"publisher","first-page":"e0258097","DOI":"10.1371\/JOURNAL.PONE.0258097","volume":"16","author":"JH Cho","year":"2021","unstructured":"Cho JH, Ko J, Lim ST (2021) Relationship between metabolic syndrome and moderate-to-vigorous physical activity among adults 18 years old and over. PLoS ONE 16(10):e0258097. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0258097","journal-title":"PLoS ONE"},{"issue":"10","key":"4947_CR25","doi-asserted-by":"publisher","first-page":"e21990","DOI":"10.1002\/SYN.21990","volume":"71","author":"E Rojas-Gutierrez","year":"2017","unstructured":"Rojas-Gutierrez E, Mu\u00f1oz-Arenas G, Trevi\u00f1o S, Espinosa B, Chavez R, Rojas K, Flores G, D\u00edaz A et al (2017) Alzheimer\u2019s disease and metabolic syndrome: a link from oxidative stress and inflammation to neurodegeneration. Synapse (New York, N.Y.) 71(10):e21990. https:\/\/doi.org\/10.1002\/SYN.21990","journal-title":"Synapse (New York, N.Y.)"},{"key":"4947_CR26","doi-asserted-by":"publisher","unstructured":"Heger I, K\u00f6hler S, Van Boxtel M, De Vugt M, Hajema KJ, Verhey F, Deckers K (2020) Raising awareness for dementia risk reduction through a public health campaign: a pre-post study. BMJ Open 10(11). https:\/\/doi.org\/10.1136\/BMJOPEN-2020-041211","DOI":"10.1136\/BMJOPEN-2020-041211"},{"key":"4947_CR27","doi-asserted-by":"publisher","first-page":"106522","DOI":"10.1016\/J.YPMED.2021.106522","volume":"147","author":"S Van Asbroeck","year":"2021","unstructured":"Van Asbroeck S, van Boxtel MPJ, Steyaert J, K\u00f6hler S, Heger I, de Vugt M, Verhey F, Deckers K (2021) Increasing knowledge on dementia risk reduction in the general population: results of a public awareness campaign. Prev Med 147:106522. https:\/\/doi.org\/10.1016\/J.YPMED.2021.106522","journal-title":"Prev Med"},{"issue":"2","key":"4947_CR28","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):e105\u2013e125. https:\/\/doi.org\/10.1016\/S2468-2667(21)00249-8","journal-title":"Lancet Public Health"},{"key":"4947_CR29","doi-asserted-by":"publisher","first-page":"481680","DOI":"10.3389\/FPHAR.2020.01168\/BIBTEX","volume":"11","author":"R Magierski","year":"2020","unstructured":"Magierski R, Sobow T, Schwertner E, Religa D (2020) Pharmacotherapy of behavioral and psychological symptoms of dementia: state of the art and future progress. Front Pharmacol 11:481680. https:\/\/doi.org\/10.3389\/FPHAR.2020.01168\/BIBTEX","journal-title":"Front Pharmacol"},{"key":"4947_CR30","doi-asserted-by":"publisher","unstructured":"Parial LL, Lam SC, Ho JYS, Suen LKP, Leung AYM (2020) Public knowledge of the influence of modifiable cardiovascular risk factors on dementia: a systematic literature review and meta-analysis. Aging Mental Health 1\u201315. https:\/\/doi.org\/10.1080\/13607863.2020.1786801","DOI":"10.1080\/13607863.2020.1786801"},{"key":"4947_CR31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/J.NEUBIOREV.2020.02.012","volume":"112","author":"F Kosel","year":"2020","unstructured":"Kosel F, Pelley JMS, Franklin TB (2020) Behavioural and psychological symptoms of dementia in mouse models of Alzheimer\u2019s disease-related pathology. Neurosci Biobehav Rev 112:634\u2013647. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2020.02.012","journal-title":"Neurosci Biobehav Rev"},{"key":"4947_CR32","doi-asserted-by":"publisher","unstructured":"Roda A, Serra-Mir G, Montoliu-Gaya L, Tiessler L, Villegas S (2022) Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease. Neural Regen Res 17(8):1666\u20131674. https:\/\/doi.org\/10.4103\/1673-5374.332127","DOI":"10.4103\/1673-5374.332127"},{"issue":"6","key":"4947_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jagp.2019.01.214","volume":"27","author":"AR Atti","year":"2019","unstructured":"Atti AR, Valente S, Iodice A, Caramella I, Ferrari B, Albert U, Mandelli L, De Ronchi D (2019) Metabolic syndrome, mild cognitive impairment, and dementia: a meta-analysis of longitudinal studies. Am J Geriatric Psychiatry 27(6):625\u2013637. https:\/\/doi.org\/10.1016\/j.jagp.2019.01.214","journal-title":"Am J Geriatric Psychiatry"},{"issue":"4","key":"4947_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/S12017-023-08746-1\/FIGURES\/1","volume":"25","author":"DE Wong Zhang","year":"2023","unstructured":"Wong Zhang DE, Tran V, Vinh A, Dinh QN, Drummond GR, Sobey CG, Jelinic M, De Silva TM (2023) Pathophysiological links between obesity and dementia. NeuroMol Med 25(4):451\u2013456. https:\/\/doi.org\/10.1007\/S12017-023-08746-1\/FIGURES\/1","journal-title":"NeuroMol Med"},{"key":"4947_CR35","doi-asserted-by":"publisher","unstructured":"Papadopoulou SK, Detopoulou P, Voulgaridou G, Tsoumana D, Spanoudaki M, Sadikou F, Papadopoulou VG, Zidrou C et al (2023). Mediterranean diet and sarcopenia features in apparently healthy adults over 65 years: a systematic review. Nutrients 15(5). https:\/\/doi.org\/10.3390\/NU15051104\/S1","DOI":"10.3390\/NU15051104\/S1"},{"issue":"9","key":"4947_CR36","doi-asserted-by":"publisher","first-page":"e2016084","DOI":"10.1001\/JAMANETWORKOPEN.2020.16084","volume":"3","author":"M Kivim\u00e4ki","year":"2020","unstructured":"Kivim\u00e4ki M, Singh-Manoux A, Batty GD, Sabia S, Sommerlad A, Floud S, Jokela M, Vahtera J et al (2020) Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Network Open 3(9):e2016084\u2013e2016084. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2020.16084","journal-title":"JAMA Network Open"},{"issue":"8","key":"4947_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.31128\/AJGP-02-23-6736","volume":"52","author":"KS Chin","year":"2023","unstructured":"Chin KS (2023) Pathophysiology of dementia. Aust J Gen Pract 52(8):516\u2013521. https:\/\/doi.org\/10.31128\/AJGP-02-23-6736","journal-title":"Aust J Gen Pract"},{"key":"4947_CR38","doi-asserted-by":"publisher","unstructured":"Fard MT, Cribb L, Nolidin K, Savage K, Wesnes K, Stough C (2020) Is there a relationship between low-grade systemic inflammation and cognition in healthy people aged 60\u201375 years? Behav Brain Res 383. https:\/\/doi.org\/10.1016\/J.BBR.2020.112502","DOI":"10.1016\/J.BBR.2020.112502"},{"key":"4947_CR39","doi-asserted-by":"publisher","unstructured":"Chen RJ, Shu Y, Zeng Y (2019) Links between adiponectin and dementia: from risk factors to pathophysiology. Front Aging Neurosci 11. https:\/\/doi.org\/10.3389\/FNAGI.2019.00356","DOI":"10.3389\/FNAGI.2019.00356"},{"issue":"6","key":"4947_CR40","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/GERONA\/GLAB267","volume":"77","author":"SS Mooldijk","year":"2022","unstructured":"Mooldijk SS, Ikram MK, Ikram MA (2022) Adiponectin, leptin, and resistin and the risk of dementia. J Gerontol Ser A Biol Sci Med Sci 77(6):1245\u20131249. https:\/\/doi.org\/10.1093\/GERONA\/GLAB267","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"4","key":"4947_CR41","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/JAMANEUROL.2015.4899","volume":"73","author":"TP Ng","year":"2016","unstructured":"Ng TP, Feng L, Nyunt MSZ, Feng L, Gao Q, Lim ML, Collinson SL, Chong MS et al (2016) Metabolic syndrome and the risk of mild cognitive impairment and progression to dementia: follow-up of the Singapore Longitudinal Ageing Study cohort. JAMA Neurol 73(4):456\u2013463. https:\/\/doi.org\/10.1001\/JAMANEUROL.2015.4899","journal-title":"JAMA Neurol"},{"issue":"12","key":"4947_CR42","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/GERONA\/GLAB195","volume":"76","author":"A Marseglia","year":"2021","unstructured":"Marseglia A, Darin-Mattsson A, Skoog J, Ryd\u00e9n L, Hadarsson-Bodin T, Kern S, Rydberg Sterner T, Shang Y et al (2021) Metabolic syndrome is associated with poor cognition: a population-based study of 70-year-old adults without dementia. J Gerontol Ser A 76(12):2275\u20132283. https:\/\/doi.org\/10.1093\/GERONA\/GLAB195","journal-title":"J Gerontol Ser A"},{"issue":"9","key":"4947_CR43","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.3390\/IJMS22094798","volume":"22","author":"G Battineni","year":"2021","unstructured":"Battineni G, Sagaro GG, Chintalapudi N, Amenta F, Tomassoni D, Tayebati SK (2021) Impact of obesity-induced inflammation on cardiovascular diseases (CVD). Int J Mol Sci 22(9):4798. https:\/\/doi.org\/10.3390\/IJMS22094798","journal-title":"Int J Mol Sci"},{"issue":"16","key":"4947_CR44","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.3390\/nu15163585","volume":"15","author":"VA Ruiz-Pozo","year":"2023","unstructured":"Ruiz-Pozo VA, Tamayo-Trujillo R, Cadena-Ullauri S, Frias-Toral E, Guevara-Ram\u00edrez P, Paz-Cruz E, Chapela S, Montalv\u00e1n M et al (2023) The molecular mechanisms of the relationship between insulin resistance and Parkinson\u2019s disease pathogenesis. Nutrients 15(16):3585. https:\/\/doi.org\/10.3390\/nu15163585","journal-title":"Nutrients"},{"key":"4947_CR45","doi-asserted-by":"publisher","unstructured":"Al-kuraishy HM, Jabir MS, Albuhadily AK, Al-Gareeb AI, & Rafeeq MF (2023) The link between metabolic syndrome and Alzheimer disease: a mutual relationship and long rigorous investigation. Ageing Res Rev 91. https:\/\/doi.org\/10.1016\/J.ARR.2023.102084","DOI":"10.1016\/J.ARR.2023.102084"},{"key":"4947_CR46","doi-asserted-by":"publisher","unstructured":"Nam GE, Kim SM, Han K, Kim NH, Chung HS, Kim JW, Han B, Cho SJ et al (2018). Metabolic syndrome and risk of Parkinson disease: a nationwide cohort study. PLoS Med 15(8). https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1002640","DOI":"10.1371\/JOURNAL.PMED.1002640"},{"issue":"8","key":"4947_CR47","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/HBM.25377","volume":"42","author":"R Lu","year":"2021","unstructured":"Lu R, Aziz NA, Diers K, St\u00f6cker T, Reuter M, Breteler MMB (2021) Insulin resistance accounts for metabolic syndrome-related alterations in brain structure. Hum Brain Mapp 42(8):2434\u20132444. https:\/\/doi.org\/10.1002\/HBM.25377","journal-title":"Hum Brain Mapp"},{"key":"4947_CR48","doi-asserted-by":"publisher","unstructured":"Shen C, Liu C, Qiu A (2023) Metabolism-related brain morphology accelerates aging and predicts neurodegenerative diseases and stroke: a UK Biobank study. Transl Psych 13(1). https:\/\/doi.org\/10.1038\/S41398-023-02515-1","DOI":"10.1038\/S41398-023-02515-1"},{"key":"4947_CR49","doi-asserted-by":"publisher","first-page":"114847","DOI":"10.1016\/J.BIOPHA.2023.114847","volume":"163","author":"A Arjunan","year":"2023","unstructured":"Arjunan A, Song J (2023) Pharmacological and physiological roles of adipokines and myokines in metabolic-related dementia. Biomed Pharmacother 163:114847. https:\/\/doi.org\/10.1016\/J.BIOPHA.2023.114847","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"4947_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/S41418-022-01062-4","volume":"30","author":"X Hildebrandt","year":"2023","unstructured":"Hildebrandt X, Ibrahim M, Peltzer N (2023) Cell death and inflammation during obesity: \u201cKnow my methods, WAT(son).\u201d Cell Death Differ 30(2):279. https:\/\/doi.org\/10.1038\/S41418-022-01062-4","journal-title":"Cell Death Differ"},{"issue":"1","key":"4947_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2337\/dc08-0272","volume":"32","author":"C Raffaitin","year":"2009","unstructured":"Raffaitin C, Gin H, Empana J-P, Helmer C, Berr C, Tzourio C, Portet F, Dartigues J-F et al (2009) Metabolic syndrome and risk for incident Alzheimer\u2019s disease or vascular dementia. Diabetes Care 32(1):169\u2013174. https:\/\/doi.org\/10.2337\/dc08-0272","journal-title":"Diabetes Care"},{"issue":"5","key":"4947_CR52","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1532-5415.2007.01139.x","volume":"55","author":"K Yaffe","year":"2007","unstructured":"Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N (2007) Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55(5):758\u2013762. https:\/\/doi.org\/10.1111\/j.1532-5415.2007.01139.x","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"4947_CR53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/alz.13439","volume":"20","author":"D Qureshi","year":"2024","unstructured":"Qureshi D, Collister J, Allen NE, Ku\u017ama E, Littlejohns T (2024) Association between metabolic syndrome and risk of incident dementia in UK Biobank. Alzheimer\u2019s & Dementia 20(1):447\u2013458. https:\/\/doi.org\/10.1002\/alz.13439","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"4947_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13098-023-01052-7\/TABLES\/5","volume":"15","author":"H Fan","year":"2023","unstructured":"Fan H, Wang Y, Ren Z, Liu X, Zhao J, Yuan Y, Fei X, Song X et al (2023) Mediterranean diet lowers all-cause and cardiovascular mortality for patients with metabolic syndrome. Diabetol Metab Syndr 15(1):1\u201316. https:\/\/doi.org\/10.1186\/S13098-023-01052-7\/TABLES\/5","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"4947_CR55","doi-asserted-by":"publisher","first-page":"102901","DOI":"10.1016\/J.DSX.2023.102901","volume":"17","author":"EK Sher","year":"2023","unstructured":"Sher EK, D\u017eidi\u0107-Krivi\u0107 A, Karahmet A, Be\u0107a-Ze\u0107o M, Farhat EK, Softi\u0107 A, Sher F (2023) Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy - a review. Diabetes Metabolic Syndrome 17(11):102901. https:\/\/doi.org\/10.1016\/J.DSX.2023.102901","journal-title":"Diabetes Metabolic Syndrome"},{"key":"4947_CR56","doi-asserted-by":"publisher","unstructured":"Castoldi A, De Souza CN, Saraiva C\u00e2mara NO, Moraes-Vieira PM (2016) The macrophage switch in obesity development. Front Immunol 6(JAN). https:\/\/doi.org\/10.3389\/FIMMU.2015.00637","DOI":"10.3389\/FIMMU.2015.00637"},{"key":"4947_CR57","doi-asserted-by":"publisher","unstructured":"Kim S, Jung UJ, Kim SR (2025) The crucial role of the blood\u2013brain barrier in neurodegenerative diseases: mechanisms of disruption and therapeutic implications. J Clin Med 14(2). https:\/\/doi.org\/10.3390\/jcm14020386","DOI":"10.3390\/jcm14020386"},{"key":"4947_CR58","doi-asserted-by":"publisher","unstructured":"Alkhalifa AE, Al-Ghraiybah NF, Odum J, Shunnarah JG, Austin N, Kaddoumi A (2023) Blood\u2013brain barrier breakdown in Alzheimer\u2019s disease: mechanisms and targeted strategies. Int J Mol Sci 24(22). https:\/\/doi.org\/10.3390\/ijms242216288","DOI":"10.3390\/ijms242216288"},{"issue":"4","key":"4947_CR59","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1523\/JNEUROSCI.4082-13.2014","volume":"34","author":"G Moln\u00e1r","year":"2014","unstructured":"Moln\u00e1r G, Farag\u00f3 N, Kocsis \u00c1K, R\u00f3zsa M, Lovas S, Boldog E, B\u00e1ldi R, Csajb\u00f3k \u00c9 et al (2014) GABAergic neurogliaform cells represent local sources of insulin in the cerebral cortex. J Neurosci Off J Soc Neurosci 34(4):1133\u20131137. https:\/\/doi.org\/10.1523\/JNEUROSCI.4082-13.2014","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"7","key":"4947_CR60","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3390\/NU14071425","volume":"14","author":"AM Capucho","year":"2022","unstructured":"Capucho AM, Cheg\u00e3o A, Martins FO, Miranda HV, Conde SV (2022) Dysmetabolism and neurodegeneration: trick or treat? Nutrients 14(7):1425. https:\/\/doi.org\/10.3390\/NU14071425","journal-title":"Nutrients"},{"key":"4947_CR61","doi-asserted-by":"publisher","unstructured":"Maiuolo J, Gliozzi M, Musolino V, Carresi C, Scarano F, Nucera S, Scicchitano M, Bosco F et al (2021) From metabolic syndrome to neurological diseases: role of autophagy. Front Cell Dev Biol 9. https:\/\/doi.org\/10.3389\/FCELL.2021.651021\/FULL","DOI":"10.3389\/FCELL.2021.651021\/FULL"},{"key":"4947_CR62","doi-asserted-by":"publisher","unstructured":"Huang J, Li C, Shang H (2022) Astrocytes in neurodegeneration: inspiration from genetics. Front Neurosci 16. https:\/\/doi.org\/10.3389\/FNINS.2022.882316","DOI":"10.3389\/FNINS.2022.882316"},{"issue":"12","key":"4947_CR63","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.3390\/antiox12122091","volume":"12","author":"G Martemucci","year":"2023","unstructured":"Martemucci G, Fracchiolla G, Muraglia M, Tardugno R, Dibenedetto RS, D\u2019Alessandro AG (2023) Metabolic syndrome: a narrative review from the oxidative stress to the management of related diseases. Antioxidants 12(12):2091. https:\/\/doi.org\/10.3390\/antiox12122091","journal-title":"Antioxidants"},{"issue":"10","key":"4947_CR64","doi-asserted-by":"publisher","first-page":"e21990","DOI":"10.1002\/syn.21990","volume":"71","author":"E Rojas-Gutierrez","year":"2017","unstructured":"Rojas-Gutierrez E, Mu\u00f1oz-Arenas G, Trevi\u00f1o S, Espinosa B, Chavez R, Rojas K, Flores G, D\u00edaz A et al (2017) Alzheimer\u2019s disease and metabolic syndrome: a link from oxidative stress and inflammation to neurodegeneration. Synapse 71(10):e21990. https:\/\/doi.org\/10.1002\/syn.21990","journal-title":"Synapse"},{"key":"4947_CR65","doi-asserted-by":"publisher","unstructured":"Ali NH, Al\u2010Kuraishy HM, Al\u2010Gareeb AI, Alexiou A, Papadakis M, Bahaa MM, Alibrahim F, Batiha GE (2024) New insight on the potential detrimental effect of metabolic syndrome on the Alzheimer disease neuropathology: mechanistic role. J Cell Mol Med 28(23). https:\/\/doi.org\/10.1111\/jcmm.70118","DOI":"10.1111\/jcmm.70118"},{"issue":"3","key":"4947_CR66","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3390\/brainsci14030284","volume":"14","author":"V Chavda","year":"2024","unstructured":"Chavda V, Yadav D, Patel S, Song M (2024) Effects of a diabetic microenvironment on neurodegeneration: special focus on neurological cells. Brain Sci 14(3):284","journal-title":"Brain Sci"},{"issue":"5","key":"4947_CR67","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","volume":"1863","author":"S Pugazhenthi","year":"2017","unstructured":"Pugazhenthi S, Qin L, Reddy PH (2017) Common neurodegenerative pathways in obesity, diabetes, and Alzheimer\u2019s disease. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis 1863(5):1037\u20131045. https:\/\/doi.org\/10.1016\/j.bbadis.2016.04.017","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Basis Dis"},{"issue":"10","key":"4947_CR68","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/BRAINSCI13101383","volume":"13","author":"A Bima","year":"2023","unstructured":"Bima A, Eldakhakhny B, Alamoudi AA, Awan Z, Alnami A, Abo-Elkhair SM, Sakr H, Ghoneim FM et al (2023) Molecular study of the protective effect of a low-carbohydrate, high-fat diet against brain insulin resistance in an animal model of metabolic syndrome. Brain Sci 13(10):1383. https:\/\/doi.org\/10.3390\/BRAINSCI13101383","journal-title":"Brain Sci"},{"issue":"4","key":"4947_CR69","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.14336\/AD.2021.1217","volume":"13","author":"Z Jiang","year":"2022","unstructured":"Jiang Z, Yin X, Wang M, Chen T, Wang Y, Gao Z, Wang Z (2022) Effects of ketogenic diet on neuroinflammation in neurodegenerative diseases. Aging Dis 13(4):1146. https:\/\/doi.org\/10.14336\/AD.2021.1217","journal-title":"Aging Dis"},{"key":"4947_CR70","doi-asserted-by":"publisher","unstructured":"Lopez-Lopez A, Valenzuela R, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL, Mu\u00f1oz A (2023) Interactions between angiotensin type-1 antagonists, statins, and ROCK inhibitors in a rat model of L-DOPA-induced dyskinesia. Antioxidants 12(7). https:\/\/doi.org\/10.3390\/ANTIOX12071454","DOI":"10.3390\/ANTIOX12071454"},{"key":"4947_CR71","doi-asserted-by":"publisher","unstructured":"Peraza-Zaldivar JA, Ponce-Guarneros JM, Cardona-Mu\u00f1oz EG, Esparza-Guerrero Y, Salda\u00f1a-Cruz AM, Gonz\u00e1lez-Vazquez SA, Gonzalez-Lopez L, Gamez-Nava JI et al (2023) Effects of renin-angiotensin system inhibitors on atrial mechanics parameters in patients with metabolic syndrome. J Cardiovasc Pharmacol Therapeutics 28. https:\/\/doi.org\/10.1177\/10742484231216807","DOI":"10.1177\/10742484231216807"},{"key":"4947_CR72","doi-asserted-by":"publisher","unstructured":"Pedrosa MA, Labandeira CM, Lago-Baameiro N, Valenzuela R, Pardo M, Labandeira-Garcia JL, Rodriguez-Perez AI (2023) Extracellular vesicles and their renin-angiotensin cargo as a link between metabolic syndrome and Parkinson\u2019s disease. Antioxidants (Basel, Switzerland) 12(12). https:\/\/doi.org\/10.3390\/ANTIOX12122045","DOI":"10.3390\/ANTIOX12122045"},{"key":"4947_CR73","doi-asserted-by":"publisher","first-page":"101919","DOI":"10.1016\/J.PNEUROBIO.2020.101919","volume":"199","author":"JL Labandeira-Garcia","year":"2021","unstructured":"Labandeira-Garcia JL, Valenzuela R, Costa-Besada MA, Villar-Cheda B, Rodriguez-Perez AI (2021) The intracellular renin-angiotensin system: friend or foe. Some light from the dopaminergic neurons. Progress Neurobiol 199:101919. https:\/\/doi.org\/10.1016\/J.PNEUROBIO.2020.101919","journal-title":"Progress Neurobiol"},{"issue":"10","key":"4947_CR74","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3390\/ANTIOX12101869","volume":"12","author":"R Franco","year":"2023","unstructured":"Franco R, Serrano-Mar\u00edn J, Navarro G, Rivas-Santisteban R (2023) The NADPH link between the renin angiotensin system and the antioxidant mechanisms in dopaminergic neurons. Antioxidants (Basel, Switzerland) 12(10):1869. https:\/\/doi.org\/10.3390\/ANTIOX12101869","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"4947_CR75","doi-asserted-by":"publisher","unstructured":"De Dios L, Collazo C, Inostroza-Nieves Y (2022) Renin-angiotensin-system increases phosphorylated tau and reactive oxygen species in human cortical neuron cell line. Biochem Biophys Rep 32. https:\/\/doi.org\/10.1016\/J.BBREP.2022.101355","DOI":"10.1016\/J.BBREP.2022.101355"},{"issue":"4","key":"4947_CR76","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/S13311-018-0646-Z","volume":"15","author":"AI Rodriguez-Perez","year":"2018","unstructured":"Rodriguez-Perez AI, Sucunza D, Pedrosa MA, Garrido-Gil P, Kulisevsky J, Lanciego JL, Labandeira-Garcia JL (2018) Angiotensin type 1 receptor antagonists protect against alpha-synuclein-induced neuroinflammation and dopaminergic neuron death. Neurotherapeutics J Am Soc Exp NeuroTherapeutics 15(4):1063\u20131081. https:\/\/doi.org\/10.1007\/S13311-018-0646-Z","journal-title":"Neurotherapeutics J Am Soc Exp NeuroTherapeutics"},{"issue":"1\u20132","key":"4947_CR77","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/03602532.2023.2186313","volume":"55","author":"A D\u017eidi\u0107-Krivi\u0107","year":"2023","unstructured":"D\u017eidi\u0107-Krivi\u0107 A, Kusturica J, Sher EK, Selak N, Osman\u010devi\u0107 N, Karahmet Farhat E, Sher F (2023) Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metab Rev 55(1\u20132):126\u2013139. https:\/\/doi.org\/10.1080\/03602532.2023.2186313","journal-title":"Drug Metab Rev"},{"key":"4947_CR78","doi-asserted-by":"publisher","first-page":"109368","DOI":"10.1016\/J.JNUTBIO.2023.109368","volume":"118","author":"EK Farhat","year":"2023","unstructured":"Farhat EK, Sher EK, D\u017eidi\u0107-Krivi\u0107 A, Banjari I, Sher F (2023) Functional biotransformation of phytoestrogens by gut microbiota with impact on cancer treatment. J Nutr Biochem 118:109368. https:\/\/doi.org\/10.1016\/J.JNUTBIO.2023.109368","journal-title":"J Nutr Biochem"},{"key":"4947_CR79","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2147\/CIA.S139163","volume":"13","author":"A Ticinesi","year":"2018","unstructured":"Ticinesi A, Tana C, Nouvenne A, Prati B, Lauretani F, Meschi T (2018) Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. Clin Interv Aging 13:1497\u20131511. https:\/\/doi.org\/10.2147\/CIA.S139163","journal-title":"Clin Interv Aging"},{"issue":"4","key":"4947_CR80","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/S11154-019-09537-5","volume":"20","author":"M Arnoriaga-Rodr\u00edguez","year":"2019","unstructured":"Arnoriaga-Rodr\u00edguez M, Fern\u00e1ndez-Real JM (2019) Microbiota impacts on chronic inflammation and metabolic syndrome - related cognitive dysfunction. Rev Endocr Metab Disord 20(4):473\u2013480. https:\/\/doi.org\/10.1007\/S11154-019-09537-5","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"4947_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-19393-0","volume":"12","author":"A Kaiyrlykyzy","year":"2022","unstructured":"Kaiyrlykyzy A, Kozhakhmetov S, Babenko D, Zholdasbekova G, Alzhanova D, Olzhayev F, Baibulatova A, Kushugulova AR et al (2022) Study of gut microbiota alterations in Alzheimer\u2019s dementia patients from Kazakhstan. Sci Rep 12(1):1\u201311. https:\/\/doi.org\/10.1038\/s41598-022-19393-0","journal-title":"Sci Rep"},{"issue":"1","key":"4947_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12974-023-02999-0\/FIGURES\/3","volume":"21","author":"D Ji","year":"2024","unstructured":"Ji D, Chen WZ, Zhang L, Zhang ZH, Chen LJ (2024) Gut microbiota, circulating cytokines and dementia: a Mendelian randomization study. J Neuroinflammation 21(1):1\u201310. https:\/\/doi.org\/10.1186\/S12974-023-02999-0\/FIGURES\/3","journal-title":"J Neuroinflammation"},{"issue":"1","key":"4947_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S12877-020-01644-2\/FIGURES\/5","volume":"20","author":"V Stadlbauer","year":"2020","unstructured":"Stadlbauer V, Engertsberger L, Komarova I, Feldbacher N, Leber B, Pichler G, Fink N, Scarpatetti M et al (2020) Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study. BMC Geriatr 20(1):1\u201313. https:\/\/doi.org\/10.1186\/S12877-020-01644-2\/FIGURES\/5","journal-title":"BMC Geriatr"},{"issue":"23","key":"4947_CR84","doi-asserted-by":"publisher","first-page":"16642","DOI":"10.3390\/IJMS242316642","volume":"24","author":"F You","year":"2023","unstructured":"You F, Harakawa Y, Yoshikawa T, Inufusa H (2023) Controlling gut microbiota by Twendee X\u00ae may contribute to dementia prevention. Int J Mol Sci 24(23):16642. https:\/\/doi.org\/10.3390\/IJMS242316642","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4947_CR85","doi-asserted-by":"publisher","first-page":"e32959","DOI":"10.1002\/AJMG.B.32959","volume":"195","author":"D Mateo","year":"2024","unstructured":"Mateo D, Marqu\u00e8s M, Domingo JL, Torrente M (2024) Influence of gut microbiota on the development of most prevalent neurodegenerative dementias and the potential effect of probiotics in elderly: a scoping review. Am J Med Genet B Neuropsychiatr Genet 195(2):e32959. https:\/\/doi.org\/10.1002\/AJMG.B.32959","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"4947_CR86","doi-asserted-by":"publisher","unstructured":"\u0141uc M, Misiak B, Paw\u0142owski M, Sta\u0144czykiewicz B, Zab\u0142ocka A, Szcze\u015bniak D, Pa\u0142\u0119ga A, Rymaszewska J (2021) Gut microbiota in dementia. Critical review of novel findings and their potential application. Progress Neuro-Psychopharmacol Biol Psych 104. https:\/\/doi.org\/10.1016\/J.PNPBP.2020.110039","DOI":"10.1016\/J.PNPBP.2020.110039"},{"issue":"3","key":"4947_CR87","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000492491","volume":"8","author":"MO Welcome","year":"2019","unstructured":"Welcome MO (2019) Current perspectives and mechanisms of relationship between intestinal microbiota dysfunction and dementia: a review. Dement Geriatr Cogn Disord Extra 8(3):360\u2013381. https:\/\/doi.org\/10.1159\/000492491","journal-title":"Dement Geriatr Cogn Disord Extra"},{"key":"4947_CR88","doi-asserted-by":"publisher","unstructured":"Pillai JA, Bena J, Bekris L, Kodur N, Kasumov T, Leverenz JB, Kashyap SR (2023) Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer\u2019s disease. Alzheimer\u2019s Res Ther 15(1). https:\/\/doi.org\/10.1186\/S13195-023-01203-Y","DOI":"10.1186\/S13195-023-01203-Y"},{"key":"4947_CR89","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/J.GERINURSE.2023.03.006","volume":"51","author":"Y Fei","year":"2023","unstructured":"Fei Y, Wang R, Lu J, Peng S, Yang S, Wang Y, Zheng K, Li R et al (2023) Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment. Geriatr Nurs 51:167\u2013175. https:\/\/doi.org\/10.1016\/J.GERINURSE.2023.03.006","journal-title":"Geriatr Nurs"},{"key":"4947_CR90","doi-asserted-by":"publisher","first-page":"110848","DOI":"10.1016\/j.pnpbp.2023.110848","volume":"128","author":"M Amidfar","year":"2024","unstructured":"Amidfar M, Askari G, Kim Y-K (2024) Association of metabolic dysfunction with cognitive decline and Alzheimer\u2019s disease: a review of metabolomic evidence. Prog Neuropsychopharmacol Biol Psychiatry 128:110848. https:\/\/doi.org\/10.1016\/j.pnpbp.2023.110848","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"4947_CR91","doi-asserted-by":"publisher","first-page":"6797","DOI":"10.1038\/s41598-024-56837-1","volume":"14","author":"T Oka","year":"2024","unstructured":"Oka T, Matsuzawa Y, Tsuneyoshi M, Nakamura Y, Aoshima K, Tsugawa H, Weiner M, Aisen P et al (2024) Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer\u2019s Disease Neuroimaging Initiative cohort. Sci Rep 14(1):6797. https:\/\/doi.org\/10.1038\/s41598-024-56837-1","journal-title":"Sci Rep"},{"issue":"11","key":"4947_CR92","doi-asserted-by":"publisher","first-page":"9736","DOI":"10.3390\/ijms24119736","volume":"24","author":"P Reveglia","year":"2023","unstructured":"Reveglia P, Paolillo C, Angiolillo A, Ferretti G, Angelico R, Sirabella R, Corso G, Matrone C et al (2023) A targeted mass spectrometry approach to identify peripheral changes in metabolic pathways of patients with Alzheimer\u2019s disease. Int J Mol Sci 24(11):9736. https:\/\/doi.org\/10.3390\/ijms24119736","journal-title":"Int J Mol Sci"},{"key":"4947_CR93","doi-asserted-by":"publisher","unstructured":"Huang Y, Chang W, Huang C, Lin C, Peng L, Chung C, Chen L, Lee W (2025) Proteo\u2010metabolomic insights for early dual physical and cognitive impairments: a search for biomarkers of healthy aging based on muscle\u2013brain crosstalk. Aging Cell 24(3). https:\/\/doi.org\/10.1111\/acel.14407","DOI":"10.1111\/acel.14407"},{"key":"4947_CR94","doi-asserted-by":"publisher","unstructured":"Tremblay-Franco M, Canlet C, Carriere A, Nakhle J, Galinier A, Portais J-C, Yart A, Dray C et al (2024). Integrative multimodal metabolomics to early predict cognitive decline among amyloid positive community-dwelling older adults. J Gerontol Ser A Biol Sci Med Sci 79(5). https:\/\/doi.org\/10.1093\/gerona\/glae077","DOI":"10.1093\/gerona\/glae077"},{"issue":"5","key":"4947_CR95","doi-asserted-by":"publisher","first-page":"4960","DOI":"10.3390\/ijms24054960","volume":"24","author":"C Yin","year":"2023","unstructured":"Yin C, Harms AC, Hankemeier T, Kindt A, de Lange ECM (2023) Status of metabolomic measurement for insights in Alzheimer\u2019s disease progression\u2014what is missing? Int J Mol Sci 24(5):4960. https:\/\/doi.org\/10.3390\/ijms24054960","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4947_CR96","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/dom.16130","volume":"27","author":"H Hong","year":"2025","unstructured":"Hong H, Fu Q, Gu P, Zhao J, Dai J, Xu K, Yang T, Dai H, Shen S (2025) Investigating the common genetic architecture and causality of metabolic disorders with neurodegenerative diseases. Diabetes Obes Metab 27(3):1337\u20131349. https:\/\/doi.org\/10.1111\/dom.16130","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"4947_CR97","doi-asserted-by":"publisher","first-page":"e0175560","DOI":"10.1371\/journal.pone.0175560","volume":"12","author":"I Huertas","year":"2017","unstructured":"Huertas I, Jes\u00fas S, Garc\u00eda-G\u00f3mez FJ, Lojo JA, Bernal-Bernal I, Bonilla-Toribio M, Mart\u00edn-Rodriguez JF, Garc\u00eda-Sol\u00eds D et al (2017) Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson\u2019s disease. PLoS ONE 12(4):e0175560. https:\/\/doi.org\/10.1371\/journal.pone.0175560","journal-title":"PLoS ONE"},{"issue":"5","key":"4947_CR98","doi-asserted-by":"publisher","first-page":"e0304410","DOI":"10.1371\/journal.pone.0304410","volume":"19","author":"Z Azizan","year":"2024","unstructured":"Azizan Z, Zali H, Mirmotalebisohi SA, Bazrgar M, Ahmadiani A (2024) Deciphering molecular bridges: unveiling the interplay between metabolic syndrome and Alzheimer\u2019s disease through a systems biology approach and drug repurposing. PLoS ONE 19(5):e0304410. https:\/\/doi.org\/10.1371\/journal.pone.0304410","journal-title":"PLoS ONE"},{"key":"4947_CR99","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.12659\/MSM.905521","volume":"23","author":"W Zhang","year":"2017","unstructured":"Zhang W, Xin L, Lu Y (2017) Integrative analysis to identify common genetic markers of metabolic syndrome, dementia, and diabetes. Med Sci Monitor 23:5885\u20135891. https:\/\/doi.org\/10.12659\/MSM.905521","journal-title":"Med Sci Monitor"},{"issue":"9","key":"4947_CR100","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/mds.29511","volume":"38","author":"M Ta","year":"2023","unstructured":"Ta M, Blauwendraat C, Antar T, Leonard HL, Singleton AB, Nalls MA, Iwaki H (2023) Genome-wide meta-analysis of cerebrospinal fluid biomarkers in Alzheimer\u2019s disease and Parkinson\u2019s disease cohorts. Mov Disord 38(9):1697\u20131705. https:\/\/doi.org\/10.1002\/mds.29511","journal-title":"Mov Disord"},{"issue":"4","key":"4947_CR101","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3233\/JAD-230093","volume":"93","author":"CM Vyas","year":"2023","unstructured":"Vyas CM, Sadreyev RI, Gatchel JR, Kang JH, Reynolds CF, Mischoulon D, Chang G, Hazra A et al (2023) Pilot study of second-generation DNA methylation epigenetic markers in relation to cognitive and neuropsychiatric symptoms in older adults. J Alzheimer\u2019s Dis 93(4):1563\u20131575. https:\/\/doi.org\/10.3233\/JAD-230093","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4947_CR102","doi-asserted-by":"publisher","first-page":"112314","DOI":"10.1016\/j.exger.2023.112314","volume":"183","author":"K McCarthy","year":"2023","unstructured":"McCarthy K, O\u2019Halloran AM, Fallon P, Kenny RA, McCrory C (2023) Metabolic syndrome accelerates epigenetic ageing in older adults: findings from The Irish Longitudinal Study on Ageing (TILDA). Exp Gerontol 183:112314. https:\/\/doi.org\/10.1016\/j.exger.2023.112314","journal-title":"Exp Gerontol"},{"issue":"9","key":"4947_CR103","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/gerona\/glac068","volume":"77","author":"RF P\u00e9rez","year":"2022","unstructured":"P\u00e9rez RF, Alba-Linares JJ, Tejedor JR, Fern\u00e1ndez AF, Calero M, Rom\u00e1n-Dom\u00ednguez A, Borr\u00e1s C, Vi\u00f1a J et al (2022) Blood DNA methylation patterns in older adults with evolving dementia. J Gerontol Ser A 77(9):1743\u20131749. https:\/\/doi.org\/10.1093\/gerona\/glac068","journal-title":"J Gerontol Ser A"},{"key":"4947_CR104","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neuroscience.2025.01.004","volume":"567","author":"A Trisal","year":"2025","unstructured":"Trisal A, Singh AK (2025) Mechanisms and early efficacy data of caloric restriction and caloric restriction mimetics in neurodegenerative disease. Neuroscience 567:235\u2013248. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.01.004","journal-title":"Neuroscience"},{"key":"4947_CR105","doi-asserted-by":"publisher","unstructured":"Zhang L, Xu H, Ding N, Li X, Chen X, Chen Z (2021) Beneficial effects on brain micro-environment by caloric restriction in alleviating neurodegenerative diseases and brain aging. Front Physiol 12. https:\/\/doi.org\/10.3389\/fphys.2021.715443","DOI":"10.3389\/fphys.2021.715443"},{"issue":"7","key":"4947_CR106","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/NU15071572","volume":"15","author":"M Portero-Tresserra","year":"2023","unstructured":"Portero-Tresserra M, Galofr\u00e9-L\u00f3pez N, Pallares E, Gimenez-Montes C, Barcia C, Granero R, Rojic-Becker D, Vale-Mart\u00ednez A et al (2023) Effects of caloric restriction on spatial object recognition memory, hippocampal neuron loss and neuroinflammation in aged rats. Nutrients 15(7):1572. https:\/\/doi.org\/10.3390\/NU15071572","journal-title":"Nutrients"},{"issue":"7","key":"4947_CR107","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/nu15071767","volume":"15","author":"L Micheli","year":"2023","unstructured":"Micheli L, Bertini L, Bonato A, Villanova N, Caruso C, Caruso M, Bernini R, Tirone F (2023) Role of hydroxytyrosol and oleuropein in the prevention of aging and related disorders: focus on neurodegeneration, skeletal muscle dysfunction and gut microbiota. Nutrients 15(7):1767. https:\/\/doi.org\/10.3390\/nu15071767","journal-title":"Nutrients"},{"key":"4947_CR108","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.foodres.2017.11.053","volume":"105","author":"M Robles-Almazan","year":"2018","unstructured":"Robles-Almazan M, Pulido-Moran M, Moreno-Fernandez J, Ramirez-Tortosa C, Rodriguez-Garcia C, Quiles JL, Ramirez-Tortosa Mc (2018) Hydroxytyrosol: bioavailability, toxicity, and clinical applications. Food Res Int 105:654\u2013667. https:\/\/doi.org\/10.1016\/j.foodres.2017.11.053","journal-title":"Food Res Int"},{"issue":"3","key":"4947_CR109","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/nu9030306","volume":"9","author":"J Peyrol","year":"2017","unstructured":"Peyrol J, Riva C, Amiot M (2017) Hydroxytyrosol in the prevention of the metabolic syndrome and related disorders. Nutrients 9(3):306. https:\/\/doi.org\/10.3390\/nu9030306","journal-title":"Nutrients"},{"issue":"4","key":"4947_CR110","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/BIOF.1356","volume":"43","author":"MC Crespo","year":"2017","unstructured":"Crespo MC, Tom\u00e9-Carneiro J, Pintado C, D\u00e1valos A, Visioli F, Burgos-Ramos E (2017) Hydroxytyrosol restores proper insulin signaling in an astrocytic model of Alzheimer\u2019s disease. BioFactors (Oxford, England) 43(4):540\u2013548. https:\/\/doi.org\/10.1002\/BIOF.1356","journal-title":"BioFactors (Oxford, England)"},{"key":"4947_CR111","doi-asserted-by":"publisher","first-page":"122498","DOI":"10.1016\/j.ijpharm.2022.122498","volume":"631","author":"M Nardi","year":"2023","unstructured":"Nardi M, Brocchini S, Somavarapu S, Procopio A (2023) Hydroxytyrosol oleate: A promising neuroprotective nanocarrier delivery system of oleuropein and derivatives. Int J Pharm 631:122498. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122498","journal-title":"Int J Pharm"},{"key":"4947_CR112","doi-asserted-by":"publisher","first-page":"136246","DOI":"10.1016\/j.foodchem.2023.136246","volume":"422","author":"X Wang","year":"2023","unstructured":"Wang X, Wang Q, Yu J, Guo X, Tong P, Yin F, Liu X, Zhou D (2023) The potential of hydroxytyrosol fatty acid esters to enhance oral bioavailabilities of hydroxytyrosol and fatty acids: Continuous and slow-release ability in small intestine and blood. Food Chem 422:136246. https:\/\/doi.org\/10.1016\/j.foodchem.2023.136246","journal-title":"Food Chem"},{"issue":"6","key":"4947_CR113","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/molecules22060870","volume":"22","author":"J-J Yuan","year":"2017","unstructured":"Yuan J-J, Qin F, Tu J-L, Li B (2017) Preparation, characterization, and antioxidant activity evaluation of liposomes containing water-soluble hydroxytyrosol from olive. Molecules 22(6):870. https:\/\/doi.org\/10.3390\/molecules22060870","journal-title":"Molecules"},{"key":"4947_CR114","doi-asserted-by":"publisher","first-page":"132182","DOI":"10.1016\/j.foodchem.2022.132182","volume":"379","author":"T Jord\u00e2nia Silva","year":"2022","unstructured":"Jord\u00e2nia Silva T, Ram\u00edrez-Carrasco P, Romero-Hasler P, Soto-Bustamante E, Barrera-Arellano D, Robert P, Gim\u00e9nez B (2022) Soybean oil organogelled emulsions as oral delivery systems of hydroxytyrosol and hydroxytyrosol alkyl esters. Food Chem 379:132182. https:\/\/doi.org\/10.1016\/j.foodchem.2022.132182","journal-title":"Food Chem"},{"issue":"14","key":"4947_CR115","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.3390\/nu15143234","volume":"15","author":"J Yoon","year":"2023","unstructured":"Yoon J, Sasaki K, Nishimura I, Hashimoto H, Okura T, Isoda H (2023) Effects of desert olive tree pearls containing high hydroxytyrosol concentrations on the cognitive functions of middle-aged and older adults. Nutrients 15(14):3234. https:\/\/doi.org\/10.3390\/nu15143234","journal-title":"Nutrients"},{"issue":"24","key":"4947_CR116","doi-asserted-by":"publisher","first-page":"15674","DOI":"10.3390\/ijms232415674","volume":"23","author":"S Terracina","year":"2022","unstructured":"Terracina S, Petrella C, Francati S, Lucarelli M, Barbato C, Minni A, Ralli M, Greco A et al (2022) Antioxidant intervention to improve cognition in the aging brain: the example of hydroxytyrosol and resveratrol. Int J Mol Sci 23(24):15674. https:\/\/doi.org\/10.3390\/ijms232415674","journal-title":"Int J Mol Sci"},{"key":"4947_CR117","doi-asserted-by":"publisher","unstructured":"Wang L, Wei Y, Sun Z, Tai W, Li H, Yin Y, Jiang L, Wang J (2024) Effectiveness and mechanisms of combined use of antioxidant nutrients in protecting against oxidative stress\u2010induced neuronal loss and related neurological deficits. CNS Neurosci Therapeutics 30(7). https:\/\/doi.org\/10.1111\/cns.14886","DOI":"10.1111\/cns.14886"},{"key":"4947_CR118","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2022.0214","author":"DA Butterfield","year":"2023","unstructured":"Butterfield DA, Boyd-Kimball D, Reed TT (2023) Cellular stress response (hormesis) in response to bioactive nutraceuticals with relevance to Alzheimer disease. Antioxid Redox Signal. https:\/\/doi.org\/10.1089\/ars.2022.0214","journal-title":"Antioxid Redox Signal"},{"issue":"20","key":"4947_CR119","doi-asserted-by":"publisher","first-page":"12348","DOI":"10.3390\/ijms232012348","volume":"23","author":"V Laghezza Masci","year":"2022","unstructured":"Laghezza Masci V, Bernini R, Villanova N, Clemente M, Cicaloni V, Tinti L, Salvini L, Taddei AR et al (2022) In vitro anti-proliferative and apoptotic effects of hydroxytyrosyl oleate on SH-SY5Y human neuroblastoma cells. Int J Mol Sci 23(20):12348. https:\/\/doi.org\/10.3390\/ijms232012348","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4947_CR120","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/S11064-021-03250-Z","volume":"46","author":"A Diaz","year":"2021","unstructured":"Diaz A, Mu\u00f1oz-Arenas G, Venegas B, V\u00e1zquez-Roque R, Flores G, Guevara J, Gonzalez-Vergara E, Trevi\u00f1o S (2021) Metforminium decavanadate (MetfDeca) treatment ameliorates hippocampal neurodegeneration and recognition memory in a metabolic syndrome model. Neurochem Res 46(5):1151\u20131165. https:\/\/doi.org\/10.1007\/S11064-021-03250-Z","journal-title":"Neurochem Res"},{"issue":"3","key":"4947_CR121","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1515\/REVNEURO-2019-0072","volume":"31","author":"BL Tang","year":"2020","unstructured":"Tang BL (2020) Could metformin be therapeutically useful in Huntington\u2019s disease? Rev Neurosci 31(3):297\u2013317. https:\/\/doi.org\/10.1515\/REVNEURO-2019-0072","journal-title":"Rev Neurosci"},{"issue":"3","key":"4947_CR122","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4103\/1673-5374.380877","volume":"19","author":"SI Gonzalez-Cano","year":"2024","unstructured":"Gonzalez-Cano SI, Flores G, Guevara J, Morales-Medina JC, Trevi\u00f1o S, Diaz A (2024) Polyoxidovanadates a new therapeutic alternative for neurodegenerative and aging diseases. Neural Regen Res 19(3):571\u2013577. https:\/\/doi.org\/10.4103\/1673-5374.380877","journal-title":"Neural Regen Res"},{"key":"4947_CR123","doi-asserted-by":"publisher","unstructured":"Du MR, Gao QY, Liu CL, Bai LY, Li T, Wei FL (2022) Exploring the pharmacological potential of metformin for neurodegenerative diseases. Front Aging Neurosci 14. https:\/\/doi.org\/10.3389\/FNAGI.2022.838173","DOI":"10.3389\/FNAGI.2022.838173"},{"issue":"9","key":"4947_CR124","doi-asserted-by":"publisher","first-page":"696","DOI":"10.2174\/1871527317666180816100203","volume":"17","author":"A Kumar","year":"2018","unstructured":"Kumar A, Dhawan A, Kadam A, Shinde A (2018) Autophagy and mitochondria: targets in neurodegenerative disorders. CNS Neurol Disord: Drug Targets 17(9):696\u2013705. https:\/\/doi.org\/10.2174\/1871527317666180816100203","journal-title":"CNS Neurol Disord: Drug Targets"},{"key":"4947_CR125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/BS.IRN.2020.01.009","volume":"155","author":"K Maiese","year":"2020","unstructured":"Maiese K (2020) Dysregulation of metabolic flexibility: the impact of mTOR on autophagy in neurodegenerative disease. Int Rev Neurobiol 155:1\u201335. https:\/\/doi.org\/10.1016\/BS.IRN.2020.01.009","journal-title":"Int Rev Neurobiol"},{"key":"4947_CR126","doi-asserted-by":"publisher","unstructured":"Onaolapo AY, Ojo FO, Adeleye OO, Falade J, Onaolapo OJ (2023) Diabetes Mellitus and energy dysmetabolism in Alzheimer\u2019s disease: understanding the relationships and potential therapeutic targets. Curr Diabetes Rev 19(8). https:\/\/doi.org\/10.2174\/1573399819666230102141154","DOI":"10.2174\/1573399819666230102141154"},{"key":"4947_CR127","doi-asserted-by":"publisher","unstructured":"Farokhi Larijani S, Hassanzadeh G, Zahmatkesh M, Radfar F, Farahmandfar M (2024) Intranasal insulin intake and exercise improve memory function in amyloid-\u03b2 induced Alzheimer\u2019s-like disease in rats: involvement of hippocampal BDNF-TrkB receptor. Behav Brain Res 460. https:\/\/doi.org\/10.1016\/J.BBR.2023.114814","DOI":"10.1016\/J.BBR.2023.114814"},{"key":"4947_CR128","doi-asserted-by":"publisher","unstructured":"Nowell J, Blunt E, Gupta D, Edison P (2023) Antidiabetic agents as a novel treatment for Alzheimer\u2019s and Parkinson\u2019s disease. Ageing Res Rev 89. https:\/\/doi.org\/10.1016\/J.ARR.2023.101979","DOI":"10.1016\/J.ARR.2023.101979"},{"key":"4947_CR129","doi-asserted-by":"publisher","unstructured":"Yang X, Feng P, Zhang X, Li D, Wang R, Ji C, Li G, H\u00f6lscher C (2019) The diabetes drug semaglutide reduces infarct size, inflammation, and apoptosis, and normalizes neurogenesis in a rat model of stroke. Neuropharmacology 158. https:\/\/doi.org\/10.1016\/J.NEUROPHARM.2019.107748","DOI":"10.1016\/J.NEUROPHARM.2019.107748"},{"key":"4947_CR130","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/J.NPEP.2018.07.003","volume":"71","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang L, Li L, H\u00f6lscher C (2018) Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson\u2019s disease mouse model. Neuropeptides 71:70\u201380. https:\/\/doi.org\/10.1016\/J.NPEP.2018.07.003","journal-title":"Neuropeptides"},{"key":"4947_CR131","doi-asserted-by":"publisher","first-page":"109952","DOI":"10.1016\/j.neuropharm.2024.109952","volume":"253","author":"C H\u00f6lscher","year":"2024","unstructured":"H\u00f6lscher C (2024) Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson\u2019s and Alzheimer\u2019s disease clinical trials: a revolution in the making? Neuropharmacology 253:109952. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109952","journal-title":"Neuropharmacology"},{"issue":"1","key":"4947_CR132","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12929-024-01090-x","volume":"31","author":"C-T Hong","year":"2024","unstructured":"Hong C-T, Chen J-H, Hu C-J (2024) Role of glucagon-like peptide-1 receptor agonists in Alzheimer\u2019s disease and Parkinson\u2019s disease. J Biomed Sci 31(1):102. https:\/\/doi.org\/10.1186\/s12929-024-01090-x","journal-title":"J Biomed Sci"},{"key":"4947_CR133","doi-asserted-by":"publisher","first-page":"113537","DOI":"10.1016\/j.intimp.2024.113537","volume":"143","author":"N Siddeeque","year":"2024","unstructured":"Siddeeque N, Hussein MH, Abdelmaksoud A, Bishop J, Attia AS, Elshazli RM, Fawzy MS, Toraih EA (2024) Neuroprotective effects of GLP-1 receptor agonists in neurodegenerative disorders: a large-scale propensity-matched cohort study. Int Immunopharmacol 143:113537. https:\/\/doi.org\/10.1016\/j.intimp.2024.113537","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4947_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-023-01266-0","volume":"26","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Orchard SG, Nelson MR, Fravel MA, Ernst ME (2024) Angiotensin receptor blockers and cognition: a scoping review. Curr Hypertens Rep 26(1):1\u201319. https:\/\/doi.org\/10.1007\/s11906-023-01266-0","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"4947_CR135","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/1440-1681.13738","volume":"50","author":"CJ Rodriguez-Ortiz","year":"2023","unstructured":"Rodriguez-Ortiz CJ, Thorwald MA, Rodriguez R, Mejias-Ortega M, Kieu Z, Maitra N, Hawkins C, Valenzuela J et al (2023) Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats. Clin Exp Pharmacol Physiol 50(3):228\u2013237. https:\/\/doi.org\/10.1111\/1440-1681.13738","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04947-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-04947-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-04947-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:02:58Z","timestamp":1760036578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-04947-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":135,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["4947"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-04947-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed equally and approved the submission of a manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}}]}}